Back to search
Regional Citrate Anticoagulation (RCA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Regional Citrate Anticoagulation (RCA) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Regional Citrate Anticoagulation (RCA) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Prismocitrate 18 is a continuous renal replacement therapy (CRRT) solution to be used as a renal replacement solution and as an anticoagulant to prevent blood c…
One of the main RRT issues is anticoagulation of the ECC, because blood contact with biomaterials causes bio-incompatibility reactions, including activation of…
The purpose of this study is to compare the efficacy and safety of an individualized two-stage calcium supplementation method versus a conventional commercial R…
The purpose of this research is to determine if an investigational new drug solution called Prismocitrate 18 lengthens extracorporeal circuit life in patients t…